Eli Lilly LLY 0.30 % increase; green up pointing triangle agreed to acquire Verve Therapeutics VERV-0.27 % decrease; red down pointing triangle for about $1 billion upfront, adding a potential ...

Pharmaceutical company Eli Lilly warning in an open letter on Thursday about the dangers of fake and compounded versions of its diabetes and weight loss medications Mounjaro and Zepbound.

Eli Lilly saw its shares jump by 15% on Thursday after unveiling positive results from a clinical trial of its experimental oral drug. REUTERS Lilly’s stock was recently up 14% at $838.80 in ...

Eli Lilly & Co. aims to offer a one-and-done heart-disease medicine by paying up to $1.3 billion for Verve Therapeutics Inc., the maker of a new gene-editing treatment, Lilly said on Tuesday ...

Eli Lilly's new weight loss drug is "transformational," obesity doctor says 02:33. Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial ...

Eli Lilly is announcing a new way to get its popular Zepbound drug. By Katie Kindelan. August 27, 2024, 7:31 AM. 4:02. An injection pen of Zepbound, a weight loss drug, is displayed in New York ...

OrderlyMeds, a provider of compounded versions of GLP-1 weight loss drugs, including Eli Lilly’s (NYSE:LLY) tirzepatide, said on Friday that a cease-and-desist letter sent by the pharma giant ...

FDA approves new treatment to slow progression of early Alzheimer's 02:45. The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, clearing the way for ...

Eli Lilly has unveiled plans to invest $27 billion in the construction of four new manufacturing plants in the United States. Getty Images. The new sites will be announced later this year and are ...

Eli Lilly will acquire biopharmaceutical firm Morphic Holding in a deal valued at $3.2 billion, both companies announced Monday, a transaction that includes an experimental medication for ...

A settlement between Eli Lilly and purchasers of its insulin drugs that would have capped prices and provided $13.5 million to resolve claims that the company inflated the drugs' cost has fallen ...

Eli Lilly has cut the prices of its two lowest doses of weight-loss drug Zepbound by releasing them as single-dose vials, the pharmaceutical company announced Tuesday. Eli Lilly said the two ...